Search research articles
Contact Us
Filters
Showing results (191-200 of 277) with videos related to
Page
of 28
Sort By:
Epilepsy Research
|
September 28, 2002
Conantokin-L, a new NMDA receptor antagonist: determinants for anticonvulsant potency
Elsie C Jimenez, Sean Donevan, Craig Walker, et al.
Epilepsia
|
February 2, 2026
Preclinical signal for a disease-modifying effect on seizure cluster severity with intermittent diazepam treatment
Qian Wu, Michelle Guignet, Jonathan Vuong, et al.
Neuropharmacology
|
August 8, 2006
Preclinical evaluation of 2,2,3,3-tetramethylcyclopropanecarbonyl-urea, a novel, second generation to valproic acid, antiepileptic drug
Eyal Sobol, Boris Yagen, H Steve White, et al.
Epilepsia
|
January 24, 2018
Potent and selective pharmacodynamic synergy between the metabotropic glutamate receptor subtype 2-positive allosteric modulator JNJ-46356479 and levetiracetam in the mouse 6-Hz (44-mA) model
Cameron S Metcalf, Brian D Klein, Misty D Smith, et al.
Epilepsia
|
July 9, 2010
Clinical and neurophysiologic features of active convulsive epilepsy in rural Kenya: a population-based study
Gilbert Munyoki, Tansy Edwards, Steve White, et al.
Biomedicines
|
September 27, 2025
Potential for Therapeutic Alteration of the Underlying Biology of Epilepsy
Michael R Sperling, Jurriaan M Peters, Qian Wu, et al.
Epilepsia
|
March 21, 2002
Anticonvulsant profile and teratogenicity of N-methyl-tetramethylcyclopropyl carboxamide: a new antiepileptic drug
Nina Isoherranen, H Steve White, Richard H Finnell, et al.
Bioanalysis
|
July 9, 2013
IS addition in bioanalysis of DBS: results from the EBF DBS-microsampling consortium
Ben L M van Baar, Tom Verhaeghe, Olivier Heudi, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
July 21, 2010
Introduction of lipidization-cationization motifs affords systemically bioavailable neuropeptide Y and neurotensin analogs with anticonvulsant activities
Brad R Green, Karen L White, Daniel R McDougle, et al.
Epilepsia
|
May 21, 2009
Electroconvulsive seizure thresholds and kindling acquisition rates are altered in mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions
James F Otto, Nanda A Singh, E Jill Dahle, et al.
Page
of 28
Search research articles
Search
Showing results (191-200 of 277) with videos related to
Sort By:
Page
of 28
Epilepsy Research
|
September 28, 2002
Conantokin-L, a new NMDA receptor antagonist: determinants for anticonvulsant potency
Elsie C Jimenez, Sean Donevan, Craig Walker, et al.
Epilepsia
|
February 2, 2026
Preclinical signal for a disease-modifying effect on seizure cluster severity with intermittent diazepam treatment
Qian Wu, Michelle Guignet, Jonathan Vuong, et al.
Neuropharmacology
|
August 8, 2006
Preclinical evaluation of 2,2,3,3-tetramethylcyclopropanecarbonyl-urea, a novel, second generation to valproic acid, antiepileptic drug
Eyal Sobol, Boris Yagen, H Steve White, et al.
Epilepsia
|
January 24, 2018
Potent and selective pharmacodynamic synergy between the metabotropic glutamate receptor subtype 2-positive allosteric modulator JNJ-46356479 and levetiracetam in the mouse 6-Hz (44-mA) model
Cameron S Metcalf, Brian D Klein, Misty D Smith, et al.
Epilepsia
|
July 9, 2010
Clinical and neurophysiologic features of active convulsive epilepsy in rural Kenya: a population-based study
Gilbert Munyoki, Tansy Edwards, Steve White, et al.
Biomedicines
|
September 27, 2025
Potential for Therapeutic Alteration of the Underlying Biology of Epilepsy
Michael R Sperling, Jurriaan M Peters, Qian Wu, et al.
Epilepsia
|
March 21, 2002
Anticonvulsant profile and teratogenicity of N-methyl-tetramethylcyclopropyl carboxamide: a new antiepileptic drug
Nina Isoherranen, H Steve White, Richard H Finnell, et al.
Bioanalysis
|
July 9, 2013
IS addition in bioanalysis of DBS: results from the EBF DBS-microsampling consortium
Ben L M van Baar, Tom Verhaeghe, Olivier Heudi, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
July 21, 2010
Introduction of lipidization-cationization motifs affords systemically bioavailable neuropeptide Y and neurotensin analogs with anticonvulsant activities
Brad R Green, Karen L White, Daniel R McDougle, et al.
Epilepsia
|
May 21, 2009
Electroconvulsive seizure thresholds and kindling acquisition rates are altered in mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions
James F Otto, Nanda A Singh, E Jill Dahle, et al.
Page
of 28